SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-22-276468
Filing Date
2022-11-03
Accepted
2022-11-03 08:56:24
Documents
52
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d403221d10q.htm   iXBRL 10-Q 841540
2 EX-31.1 d403221dex311.htm EX-31.1 10743
3 EX-31.2 d403221dex312.htm EX-31.2 10702
4 EX-32.1 d403221dex321.htm EX-32.1 5891
  Complete submission text file 0001193125-22-276468.txt   3785607

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20220930.xsd EX-101.SCH 29354
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdgl-20220930_cal.xml EX-101.CAL 26932
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdgl-20220930_def.xml EX-101.DEF 105491
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20220930_lab.xml EX-101.LAB 260531
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20220930_pre.xml EX-101.PRE 199587
46 EXTRACTED XBRL INSTANCE DOCUMENT d403221d10q_htm.xml XML 535459
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 221356437
SIC: 2834 Pharmaceutical Preparations